FDA Inspection 1181620 - Recipharm Monts - October 18, 2022

Record Details

This FDA Inspection record concerns Recipharm Monts, with an inspection on October 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Recipharm Monts
Inspection Date: October 18, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 1e8094d2-a501-42d5-a694-2a4acf3c64b3

Violation Codes9

21 CFR 211.113(b)21 CFR 211.160(a)21 CFR 211.166(a)(3)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.42(c)(10)(ii)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.